Skip to main content

Fieldpoint Private Securities, LLC

SEC CIK
0001706170
Latest filing
Aug 5, 2022

MYGN holding history

Myriad Genetics Inc in every 13F filed by Fieldpoint Private Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MYGN overviewAll 13F holders of MYGNFull Q2 2022 holdings

Shares (Q4 2021)
0
Sold out in Q4 2021
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q1 2021
Holdings of MYGN by Fieldpoint Private Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20210$00.0%−5−100.0%Sold outHolders
Q3 20215$00.0%00.0%UnchangedHolders
Q2 20215$00.0%−30−85.7%ReducedHolders
Q1 202135$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.